203 related articles for article (PubMed ID: 29496635)
1. Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.
Kelm-Nelson CA; Trevino MA; Ciucci MR
Neuroscience; 2018 May; 379():126-141. PubMed ID: 29496635
[TBL] [Abstract][Full Text] [Related]
2. Early-onset Parkinsonian behaviors in female Pink1-/- rats.
Marquis JM; Lettenberger SE; Kelm-Nelson CA
Behav Brain Res; 2020 Jan; 377():112175. PubMed ID: 31542395
[TBL] [Abstract][Full Text] [Related]
3. Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.
Grant LM; Kelm-Nelson CA; Hilby BL; Blue KV; Paul Rajamanickam ES; Pultorak JD; Fleming SM; Ciucci MR
J Neurosci Res; 2015 Nov; 93(11):1713-27. PubMed ID: 26234713
[TBL] [Abstract][Full Text] [Related]
4. Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.
Johnson RA; Kelm-Nelson CA; Ciucci MR
J Parkinsons Dis; 2020; 10(2):489-504. PubMed ID: 32065805
[TBL] [Abstract][Full Text] [Related]
5. Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.
Kelm-Nelson CA; Brauer AFL; Barth KJ; Lake JM; Sinnen MLK; Stehula FJ; Muslu C; Marongiu R; Kaplitt MG; Ciucci MR
Brain Res; 2018 Feb; 1680():1-12. PubMed ID: 29229503
[TBL] [Abstract][Full Text] [Related]
6. Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
Stevenson SA; Ciucci MR; Kelm-Nelson CA
PLoS One; 2019; 14(8):e0220734. PubMed ID: 31374106
[TBL] [Abstract][Full Text] [Related]
7. Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease.
Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
Behav Brain Res; 2021 Sep; 414():113514. PubMed ID: 34358571
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
Behav Brain Res; 2022 Feb; 418():113642. PubMed ID: 34755639
[TBL] [Abstract][Full Text] [Related]
10. Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset parkinsonism in Pink1 knockout rats.
Kelm-Nelson CA; Gammie S
BMC Genomics; 2020 Sep; 21(1):625. PubMed ID: 32942992
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum.
Dehorter N; Lozovaya N; Mdzomba BJ; Michel FJ; Lopez C; Tsintsadze V; Tsintsadze T; Klinkenberg M; Gispert S; Auburger G; Hammond C
J Neurosci; 2012 Dec; 32(50):18047-53. PubMed ID: 23238720
[TBL] [Abstract][Full Text] [Related]
12. Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
Kelm-Nelson CA; Yang KM; Ciucci MR
J Parkinsons Dis; 2015; 5(4):749-63. PubMed ID: 26577653
[TBL] [Abstract][Full Text] [Related]
13. CART modulates the effects of levodopa in rat model of Parkinson's disease.
Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
Behav Brain Res; 2016 Mar; 301():262-72. PubMed ID: 26771081
[TBL] [Abstract][Full Text] [Related]
14. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
15. Aging accelerates locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression.
Soto I; McManus R; Navarrete W; Kasanga EA; Doshier K; Nejtek VA; Salvatore MF
Exp Neurol; 2024 Jun; 376():114771. PubMed ID: 38580154
[TBL] [Abstract][Full Text] [Related]
16. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
17. Decreased approach behavior and nucleus accumbens immediate early gene expression in response to Parkinsonian ultrasonic vocalizations in rats.
Pultorak JD; Kelm-Nelson CA; Holt LR; Blue KV; Ciucci MR; Johnson AM
Soc Neurosci; 2016; 11(4):365-79. PubMed ID: 26313334
[TBL] [Abstract][Full Text] [Related]
18. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
[TBL] [Abstract][Full Text] [Related]
19. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
20. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
